trending Market Intelligence /marketintelligence/en/news-insights/trending/uE_00NpKMnlQym7xb2V3jA2 content esgSubNav
Log in to other products


Looking for more?

Contact Us
In This List

XOMA closes rights offering


Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge


COVID-19 Impact & Recovery: Private Equity

COVID-19 Impact & Recovery: Corporates


COVID-19 Impact & Recovery: Investment Banking

XOMA closes rights offering

XOMA Corp. closed its previously announced rights offering, raising $20 million.

The Emeryville, Calif.-based drug developer sold 285,689 common shares at $13 apiece and 1,252.772 series Y preferred shares at $13,000 apiece.

Existing stockholders bought 570.126 of the series Y preferred shares, while BVF Partners LP, XOMA's largest stockholder, exercised its oversubscription rights and acquired the remaining 682.646 series Y preferred shares.

D.F. King & Co. Inc. acted as information agent for the rights offering.